Skip to main content
Home > Week in Review > Deals

Chronological Index of : Deals

 Current Issue
  • Aeterna Zentaris, Medical University of South Carolina deal

    Aeterna Zentaris Inc. (TSX:AEZ;NASDAQ:AEZS), Quebec City, Quebec Medical University of South Carolina, Charleston, S.C. Business: Pharmaceuticals Aeterna Zentaris will transfer its discovery library of 100,000 compounds…

    Published on 4/20/2015
  • Argos, Chongqing Lummy Pharmaceutical deal

    Argos Therapeutics Inc. (NASDAQ:ARGS), Durham, N.C. Chongqing Lummy Pharmaceutical Co. Ltd. (SGX:300006), Chongqing, China Business: Infectious, Cancer Argos granted Chongquing Lummys Lummy Co. Ltd. subsidiary exclusive…

    Published on 4/20/2015
  • Bayer, Broad Institute deal

    Bayer AG (Xetra:BAYN), Leverkusen, Germany Broad Institute of MIT and Harvard, Cambridge, Mass. Business: Cancer, Cardiovascular, Genomics Bayers Bayer Healthcare LLC subsidiary and the institute added cardiovascular …

    Published on 4/20/2015
  • Bristol-Myers, Eli Lilly deal

    Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Business: Cancer Bristol-Myers will transfer full commercial rights to Eli Lilly for Erbitux cetuximab in the U.S., …

    Published on 4/20/2015
  • Can-Fite, Cipher deal

    Can-Fite BioPharma Ltd. (Tel Aviv:CFBI;NYSE-M:CANF), Petah Tikva, Israel Cipher Pharmaceuticals Inc. (TSX:DND;NASDAQ:CPHR), Mississauga, Ontario Business: Autoimmune Can-Fite granted Cipher rights to commercialize Can-…

    Published on 4/20/2015
  • Cancer Research Technology, Institute of Cancer Research, University of Manchester, Wellcome Trust, Basilea deal

    Cancer Research Technology Ltd., London, U.K. The Institute of Cancer Research, London, U.K. University of Manchester, Manchester, U.K. Wellcome Trust, London, U.K. Basilea Pharmaceutica AG (SIX:BSLN), Basel, …

    Published on 4/20/2015
  • CAPP Medical, Roche deal

    CAPP Medical, Palo Alto, Calif. Roche (SIX:ROG;OTCQX:RHHBY), Basel, Switzerland Business: Cancer Roche acquired CAPP, a genomics research company developing technology to detect and monitor circulating tumor DNA. Roche …

    Published on 4/20/2015
  • CareFusion, Becton Dickinson deal

    CareFusion Corp., San Diego, Calif. Becton Dickinson and Co. (NYSE:BDX), Franklin Lakes, N.J. Business: Supply/Service Becton acquired CareFusion, which provides hospitals with products and services, for $58 per share …

    Published on 4/20/2015
  • City of Hope, Mustang Therapeutics deal

    City of Hope, Duarte, Calif. Mustang Therapeutics Inc., Duarte, Calif. Business: Cancer, Gene/Cell therapy City of Hope granted Mustang exclusive, worldwide rights to develop and commercialize a portfolio of clinical-…

    Published on 4/20/2015
  • Cold Spring Harbor Laboratory, GlaxoSmithKline deal

    Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. GlaxoSmithKline plc (LSE:GSK;NYSE:GSK), London, U.K. Business: Endocrine/Metabolic The partners are discovering and developing small molecules to regulate the …

    Published on 4/20/2015
  • Genomics England, Helomics deal

    Genomics England Ltd., London, U.K. Helomics Corp., Pittsburgh, Pa. Business: Diagnostic Helomics partnered with Genomics England, a company owned and funded by the U.K. Department of Health, to use Helomics tumor …

    Published on 4/20/2015
  • iDD Biotech, Genmab deal

    iDD Biotech S.A.S., Lyon, France Genmab A/S (CSE:GEN;OTCBB:GMXAY), Copenhagen, Denmark Business: Cancer Genmab purchased from iDD preclinical antibodies targeting tumor necrosis factor (TNF) receptor superfamily member …

    Published on 4/20/2015
  • Intarcia, Numab deal

    Intarcia Therapeutics Inc., Boston, Mass. Numab AG, Waedensil, Switzerland Business: Autoimmune, Endocrine/Metabolic Numab and Intarcia partnered to use Numabs antibody fragment technology and Intarcias antibody …

    Published on 4/20/2015
  • J&J, Depomed deal

    Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Depomed Inc. (NASDAQ:DEPO), Newark, Calif. Business: Neurology Depomed completed its purchase of U.S. rights to the Nucynta tapentadol analgesic franchise from Johnson…

    Published on 4/20/2015
  • J&J, University College Cork deal

    Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. University College Cork, Cork, Ireland Business: Autoimmune The universitys Alimentary Pharmabiotic Centers Microbiome Institute partnered with the pharmas Janssen …

    Published on 4/20/2015
  • Japan Health Sciences Foundation, Takeda, Kaketsuken deal

    Japan Health Sciences Foundation, Tokyo, Japan Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Kaketsuken, Kumamoto, Japan Business: Cancer Takeda transferred its worldwide patent rights covering a preclinical…

    Published on 4/20/2015
  • Lexicon, Ipsen deal

    Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX), The Woodlands, Texas Ipsen Group (Euronext:IPN;Pink:IPSEY), Boulogne-Billancourt, France Business: Cancer, Endocrine/Metabolic The companies added Canada to a 2014 deal …

    Published on 4/20/2015
  • Lundbeck, Ovid Therapeutics deal

    H. Lundbeck A/S (CSE:LUN), Copenhagen, Denmark Ovid Therapeutics Inc., New York, N.Y. Business: Neurology Lundbeck granted Ovid exclusive, worldwide rights to develop and commercialize gaboxadol (OV101). Ovid plans to …

    Published on 4/20/2015
  • Mesoblast, Celgene deal

    Mesoblast Ltd. (ASX:MSB;Pink:MBLTY), Melbourne, Australia Celgene Corp. (NASDAQ:CELG), Summit, N.J. Business: Cancer, Transplant Celgene purchased 15.3 million shares of Mesoblast stock for A$58.4 million ($44.2 million…

    Published on 4/20/2015
  • Myriad Genetics, AstraZeneca deal

    Myriad Genetics Inc. (NASDAQ:MYGN), Salt Lake City, Utah AstraZeneca plc (LSE:AZN;NYSE:AZN), London, U.K. Business: Pharmacogenetics AstraZeneca and Myriad expanded a 2013 deal and will use Myriads BRACAnalysis CDx test…

    Published on 4/20/2015
  • Ono Pharmaceutical, China Chemical & Pharmaceutical deal

    Ono Pharmaceutical Co. Ltd. (Tokyo:4528), Osaka, Japan China Chemical & Pharmaceutical Co. Ltd. (CCPC) (Taiwan:1701), Taipei, Taiwan Business: Neurology Ono granted CCPC exclusive, Taiwanese rights to develop and …

    Published on 4/20/2015
  • PatientsLikeMe, AstraZeneca deal

    PatientsLikeMe Inc., Cambridge, Mass. AstraZeneca plc (LSE:AZN;NYSE:AZN), London, U.K. Business: Pharmaceuticals PatientsLikeMe granted AstraZeneca access to its global network of patient-reported outcomes data under a …

    Published on 4/20/2015
  • Population Genetics, Case Western Reserve University deal

    Population Genetics Technologies Ltd., Babraham, U.K. Case Western Reserve University, Cleveland, Ohio Business: Diagnostic Population Genetics and Case Western partnered to use Population Genetics VeriTag next-…

    Published on 4/20/2015
  • Scilex Pharmaceuticals, Itochu deal

    Scilex Pharmaceuticals Inc., West Chester, Pa. Itochu Corp. (Tokyo:8001;Pink:ITOCY), Tokyo, Japan Business: Neurology Itochus Itochu Chemical Frontier Corp. company made an undisclosed investment in neurology company …

    Published on 4/20/2015
  • T-Cell Factory, Kite Pharma deal

    T-Cell Factory B.V., Amsterdam, the Netherlands Kite Pharma Inc. (NASDAQ:KITE), Los Angeles, Calif. Business: Cancer Cancer company Kite acquired T-Cell Factory for EUR20 million ($21.1 million) in cash and stock and up…

    Published on 4/20/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993